Literature DB >> 3258143

In vitro activities of five new quinolones against 88 genital and neonatal Haemophilus isolates.

R Quentin1, N Koubaa, B Cattier, M Gavignet, A Goudeau.   

Abstract

In vitro activities of five new quinolones against 88 strains of Haemophilus influenzae and H. parainfluenzae isolated from genitourinary or neonatal infections were studied. All strains were susceptible, and MICs were similar to those for respiratory tract isolates. However, H. influenzae biotype IV appeared to be more susceptible to norfloxacin, enoxacin, and ciprofloxacin than the other biotypes were.

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3258143      PMCID： PMC172118          DOI： 10.1128/AAC.32.1.147

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  11 in total

1.  Haemophilus in the upper respiratory tract of children. A bacteriological, serological and clinical investigation.

Authors:  M Kilian; J Heine-Jensen; P Bülow
Journal:  Acta Pathol Microbiol Scand B Microbiol Immunol       Date:  1972

Review 2.  New antibiotics: areas of appropriate use.

Authors:  H C Neu
Journal:  J Infect Dis       Date:  1987-03       Impact factor: 5.226

3.  Antibacterial activities of ciprofloxacin, norfloxacin, oxolinic acid, cinoxacin, and nalidixic acid.

Authors:  A L Barry; R N Jones; C Thornsberry; L W Ayers; E H Gerlach; H M Sommers
Journal:  Antimicrob Agents Chemother       Date:  1984-05       Impact factor: 5.191

4.  Haemophilus influenzae: comparison of respiratory tract isolates with genitourinary tract isolates.

Authors:  W L Albritton; J L Brunton; M Meier; M N Bowman; L A Slaney
Journal:  J Clin Microbiol       Date:  1982-11       Impact factor: 5.948

5.  Nontypable Haemophilus influenzae (biotype 4) as a neonatal, maternal, and genital pathogen.

Authors:  R J Wallace; C J Baker; F J Quinones; D G Hollis; R E Weaver; K Wiss
Journal:  Rev Infect Dis       Date:  1983 Jan-Feb

6.  Comparative evaluation of enoxacin, ofloxacin, ampicillin, and chloramphenicol for treatment of experimental Haemophilus influenzae pneumonia.

Authors:  B Kemmerich; K Borner; J E Pennington
Journal:  Antimicrob Agents Chemother       Date:  1987-03       Impact factor: 5.191

7.  Neonatal sepsis due to nontypable Haemophilus influenzae.

Authors:  P Campognone; D B Singer
Journal:  Am J Dis Child       Date:  1986-02

8.  [Maternal-fetal Haemophilus influenzae infections].

Authors:  R Quentin; A Goudeau; E Burfin; G Pinon; C Berger; J Laugier; J H Soutoul
Journal:  Presse Med       Date:  1987-06-20       Impact factor: 1.228

9.  Novel method of biotyping Haemophilus influenzae that uses API 20e.

Authors:  R L Holmes; L M DeFranco; M Otto
Journal:  J Clin Microbiol       Date:  1982-06       Impact factor: 5.948

10.  The comparative activity of twelve 4-quinolone antimicrobials against Haemophilus influenzae and Streptococcus pneumoniae.

Authors:  G L Ridgway; M D O'Hare; D Felmingham; R N Grüneberg
Journal:  Drugs Exp Clin Res       Date:  1985
View more
  10 in total

1.  Reduced levofloxacin susceptibility and tetracycline resistance in a clinical isolate of Haemophilus quentini identified by 16S rRNA sequencing.

Authors:  Gannon C Mak; P L Ho; Cindy W S Tse; Susanna K P Lau; Samson S Y Wong
Journal:  J Clin Microbiol       Date:  2005-10       Impact factor: 5.948

2.  Aerosol delivery of liposome-encapsulated ciprofloxacin: aerosol characterization and efficacy against Francisella tularensis infection in mice.

Authors:  J Conley; H Yang; T Wilson; K Blasetti; V Di Ninno; G Schnell; J P Wong
Journal:  Antimicrob Agents Chemother       Date:  1997-06       Impact factor: 5.191

Review 3.  Enoxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  J M Henwood; J P Monk
Journal:  Drugs       Date:  1988-07       Impact factor: 9.546

4.  Active copper- and zinc-containing superoxide dismutase in the cryptic genospecies of Haemophilus causing urogenital and neonatal infections discriminates them from Haemophilus influenzae sensu stricto.

Authors:  Paul R Langford; Brian J Sheehan; Taheed Shaikh; J Simon Kroll
Journal:  J Clin Microbiol       Date:  2002-01       Impact factor: 5.948

Review 5.  Pefloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  J P Gonzalez; J M Henwood
Journal:  Drugs       Date:  1989-05       Impact factor: 9.546

6.  Genetic characterization of a cryptic genospecies of Haemophilus causing urogenital and neonatal infections.

Authors:  R Quentin; C Martin; J M Musser; N Pasquier-Picard; A Goudeau
Journal:  J Clin Microbiol       Date:  1993-05       Impact factor: 5.948

7.  Biotypes of Haemophilus influenzae that are associated with noninvasive infections.

Authors:  J J Harper; M H Tilse
Journal:  J Clin Microbiol       Date:  1991-11       Impact factor: 5.948

Review 8.  Fluoroquinolone antimicrobial agents.

Authors:  J S Wolfson; D C Hooper
Journal:  Clin Microbiol Rev       Date:  1989-10       Impact factor: 26.132

9.  Genetic identification of cryptic genospecies of Haemophilus causing urogenital and neonatal infections by PCR using specific primers targeting genes coding for 16S rRNA.

Authors:  R Quentin; R Ruimy; A Rosenau; J M Musser; R Christen
Journal:  J Clin Microbiol       Date:  1996-06       Impact factor: 5.948

10.  Haemophilus influenzae septic abortion.

Authors:  Thomas L Cherpes; Shimon Kusne; Sharon L Hillier
Journal:  Infect Dis Obstet Gynecol       Date:  2002
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.